German generics maker Stada is plunking down 56 million euro ($76.6 million) for the U.K. pharma group Forum Bioscience. Antitrust regulators will have to bless the deal. Report [1]
Links:
[1] http://www.hemscott.com/news/latest-news/item.do?newsId=48500919003055